One may speculate this to be a result of a smaller fraction of EGFR-expressing tumor-derived sEVs in the liquid biopsy in PE020 than in PE011, which in turn may be a consequence of the different treatment lines among these two patients. This evidence concerns the gene EGFR and neoplasm.